期刊文献+

结直肠癌肝转移的临床特点以及预后分析 被引量:3

下载PDF
导出
摘要 目的对结直肠癌发生肝转移的患者的临床特点以及预后进行简要的分析与探讨。方法我院治疗的结直肠癌发生肝转移患者28例,所有患者均于手术治疗前经CT扫描检查发现肝脏内有癌组织的转移。对患者的癌细胞的转移部位、转移病灶数、癌细胞分化程度以及病灶转移治疗方法等方面进行分析。结果治疗后患者的平均存活时间为(14±7.27)个月。患者结直肠癌发生肝转移主要以双叶、多发的高中分析腺癌为主。采用手术加化疗可以有效的延长患者的生存时间。患者发生肝转移的部位、转移的数目、肿瘤的分化程度以及治疗方法对患者的预后产生明显的影响。结论对结直肠癌发生肝转移的患者给予准确的诊断与及时的治疗能够获得相对良好的预后效果,值得在今后的临床诊治过程中对其予以注意。
作者 宋亚金
出处 《中国实用医药》 2012年第18期132-133,共2页 China Practical Medicine
  • 相关文献

参考文献3

  • 1周志伟,任镜清,万德森,陈功,卢震海,潘志忠,李力人,伍小军,丁培荣.结直肠癌肝转移患者预后的多因素分析[J].癌症,2006,25(9):1149-1152. 被引量:30
  • 2周伟平.结直肠癌肝转移的治疗进展.中华胃肠外科杂志,2009,28(21):129-130.
  • 3李强.影响结直肠癌肝转移手术切除患者预后的多因素分析.中华普通外科杂志,2009,12(23):1231-1232.

二级参考文献14

  • 1华贻军,洪明晃,罗东华,邱枋,郭灵,张国义.406例鼻咽癌患者预后多因素分析[J].中国肿瘤临床,2005,32(8):435-438. 被引量:60
  • 2Kindler H L,Shulman K L.Metastatic colorectal cancer[J].Curr Treat Options Oncol,2001,2(6):459-471.
  • 3Adam R,Avisar E,Ariche A,et al.Five year survival following hepatic resection after neoadjuvent chemotherapy for nonresectable colorectal metastases[J].Ann Surg Oncol.2001,8(4):347-353.
  • 4Monika C,Johamna L,Ulf-Hakan S,et al.Estimating the probability of cancer with several tumor markers in patients with colorectal disease[J].Oncology,2004,66 (4):296-302.
  • 5Cady B,Jenkins R L,Steele G D,et al.Surgical margin in hepatic resection for colorectal metastasis:a critical and improvable determinant of outcome[J].Ann Surg,1998,227(4):566-571.
  • 6Hiroyuki K,Kazuhiko Y,Keiichiro I,et al.A new staging system for colorectal carcinoma with liver metastasis[J].Anticancer Res,2005,25(2B):1251-1255.
  • 7Wang J Y,Chiang J M,Jeng L B,et al.Resection of liver metastases from colorectal cancer:are there any truly significant clinical prognosticators[J].Dis Colon Rectum,1996,39(8):847-51.
  • 8Scheele J,Stang R,Altendorf-Hofmann A,et al.Resection of colorectal liver metastases[J].World J Surg,1995,19(1):59-71.
  • 9Christophe L,Antonio S,Eric R,et al.Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis[J].J Am Coil Surg,2004,198(6):884-891.
  • 10Ercolani G,Grazi G L,Ravaioli M,et al.Liver resection for multiple colorectal metastases:influence of parenchymal involvement and total tumor volume,vs number or location,on long-term survival[J].Arch Surg,2002,137(10):1187-1192.

共引文献30

同被引文献29

  • 1Akiyoshi K, Yamada Y, Honma Y, et al. KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencing[J]. Anticancer Res,2013,33 (5) :2129-2134.
  • 2Narayanan G, Barbery K, Suthar R, et al. Transarterial chemoemboliza- tion using DEBIRI for treatment of hepatic metastases from colorectal cancer[ J ]. Anticancer Res ,2013,33 ( 5 ) :2077-2083.
  • 3Prenen H,Veeehione L, Van Cutsem E. Role of targeted agents in me- tastatic eolorectal cancer [ J]. Target Oncol, 2013,8 ( 2 ) : 83-96.
  • 4Ricotta R, Sartore-Bianchi A, Verrioli A, et al. Regorafenib for meta- static colorectal cancer [ J ]. Lancet, 2013,381 ( 9877 ) : 1537.
  • 5Krpata DM, Keller DS, Samia H, et al. Evaluation of inflammatorymarkers as predictors of hospital stay and unplanned readmission after cotorectal surgery[J]. Pol Przegl Chir,2013,85(4) :198-203.
  • 6Koca D, Binicier C, Oztop I, et al. Prognostic factors affecting recur- rence and survival in patients with locally advanced rectal cancer [J]. J BUON,2012,17(2) :291-298.
  • 7Narayanan G, Barbery K, Suthar R,et al. Transarterial chemoembo- lizationusing DEBIRI for treatment of hepatic metastases from color- ectalcancer[ J ]. Anticancer Res,2013,33 (5) :2077 - 2083.
  • 8Prenen H,Vecchione L,Van Cutsem E. Role of targeted agents in metastatic colorectal cancer [ J ]. Target Oncol, 2013,8 ( 2 ) : 83 - 96.
  • 9Iversen LH. Aspects of survival from colorectal cancer in Denmark [J]. Dan ned J,2012,59(4) :B4428.
  • 10Koca D, Binicier C,Oztop I,et at. Prognostic factors affecting recur- renceand survival in patients with locally advanced rectal cancer [J]. JBUON,2012,17(2) :291-298.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部